Alunbrig 90 mg/1
brigatinib · TABLET, FILM COATED · Takeda Pharmaceuticals America, Inc.
Alunbrig (brigatinib) is an oral tablet used to treat certain types of lung cancer, specifically anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer. It works by blocking specific proteins that help cancer cells grow.
Key Facts
- Brand Name
- Alunbrig
- Generic Name
- brigatinib
- NDC Code (Product)
63020-090- Manufacturer
- Takeda Pharmaceuticals America, Inc.
- Strength
- 90 mg/1
- Dosage Form
- TABLET, FILM COATED
- Route
- ORAL
- Marketing Status
- Application #
- NDA208772
- Drug Class
- Kinase Inhibitor [EPC]
- Marketing Start
- 04/28/2017
Recall History
No Recall HistoryFrequently Asked Questions
What is Alunbrig used for?
Alunbrig (brigatinib) is an oral tablet used to treat certain types of lung cancer, specifically anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer. It works by blocking specific proteins that help cancer cells grow.
Is Alunbrig a controlled substance?
Alunbrig is not classified as a controlled substance by the DEA.
What is the generic name for Alunbrig?
The generic name for Alunbrig is brigatinib. There are no other listed brand versions of brigatinib.
What is the NDC code for Alunbrig 90 mg/1?
The NDC (National Drug Code) for Alunbrig 90 mg/1 is 63020-090, listed by Takeda Pharmaceuticals America, Inc..
Other Alunbrig Dosages
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)